Perioperative Antihypertensive Treatment in Patients With Spontaneous Intracerebral Hemorrhage
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Background—Studies on antihypertensive treatment for surgical patients with spontaneous intracerebral hemorrhage are insufficient. This pilot study was conducted to investigate the safety of the perioperative intensive blood pressure lowering in surgical patients with spontaneous intracerebral hemorrhage.
Methods—This study was a prospective, parallel, randomized, assessor-blinded trial. Patients allocated to the intensive group received perioperative intensive antihypertensive treatment aiming to achieve a target systolic blood pressure between 120 and 140 mm Hg, whereas the patients in the conservative group received conservative treatment aiming to achieve a target systolic blood pressure between 140 and 180 mm Hg for 7 days. The primary outcome was the rate of rehemorrhage at 7 days after surgery.
Results—Rehemorrhage was noted in 11 patients (11%) in the intensive group and 14 (14%) in the conservative group (P=0.689). There was no significant difference in mortality at 7 days (4.0% versus 10.0%; P=0.164), 30 days (10.4% versus 17.2%; P=0.247), and 90 days (13.5% versus 18.2%; P=0.490) between the 2 groups.
Conclusions—Perioperative intensive blood pressure lowering was not associated with a reduced incidence of rehemorrhage, death, or other serious adverse events.
Clinical Trial Registration—URL: http://www.chictr.org.cn/. Unique identifier: ChiCTR-TRC-13004304.
- antihypertensive agents
- blood pressure
- cerebral hemorrhage
- prospective studies
- randomized controlled trial
- Received June 2, 2016.
- Revision received September 10, 2016.
- Accepted October 18, 2016.
- © 2016 American Heart Association, Inc.